Benign Blood Diseases
The world-renowned experts at the OSUCCC – James are transforming the way blood diseases are prevented, detected and treated.
Benign blood diseases are not cancerous; however, they are complex, and each patient’s disease is different, behaving differently in the bodies they’re in and calling for a tailored, individualized treatment plan for each patient.
To deliver the most effective treatments, our experts identify and understand benign blood disorders at the biologic and genetic levels, unlocking the molecular code of a patient’s illness and pinpointing what makes each disease grow — then discovering what stops it.
Our team of benign hematology subspecialists spans a broad range of medical disciplines, including hematologists, pharmacists, radiologists and more — all specializing in benign blood disorder research, prevention, detection and treatment.
It’s that subspecialization and singular focus that enable us to discover, develop and deliver the most targeted therapies for each individual patient.
And that means our collective expertise leads to improving outcomes, faster responses, fewer side effects and more hope for patients everywhere.